Global Atorvastatin Calcium Market Growth 2023-2029

Global Atorvastatin Calcium Market Growth 2023-2029

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
LPI (LP Information)' newest research report, the “Atorvastatin Calcium Industry Forecast” looks at past sales and reviews total world Atorvastatin Calcium sales in 2022, providing a comprehensive analysis by region and market sector of projected Atorvastatin Calcium sales for 2023 through 2029. With Atorvastatin Calcium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atorvastatin Calcium industry.
This Insight Report provides a comprehensive analysis of the global Atorvastatin Calcium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atorvastatin Calcium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Atorvastatin Calcium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atorvastatin Calcium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atorvastatin Calcium.
The global Atorvastatin Calcium market size is projected to grow from US$ 214.2 million in 2022 to US$ 362 million in 2029; it is expected to grow at a CAGR of 362 from 2023 to 2029.
The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.
This report presents a comprehensive overview, market shares, and growth opportunities of Atorvastatin Calcium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Chemical Synthesis
Biocatalysis
Segmentation by application
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
DSM Sinochem Pharmaceuticals
Ind-Swift
Cadila Pharmaceuticals
Morepen
Sun Pharmaceutical Industries
MSN Laboratories
Dr. Reddy's
Teva Pharmaceutical Industries
Apotex Pharmachem
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
Key Questions Addressed in this Report
What is the 10-year outlook for the global Atorvastatin Calcium market?
What factors are driving Atorvastatin Calcium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atorvastatin Calcium market opportunities vary by end market size?
How does Atorvastatin Calcium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.